U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
165661165661Efficacy/Safety of Lansoprazole in Patients With Frequent HeartburnCompletedNo Results AvailableHeartburnDrug: Lanzoprazolehttps://ClinicalTrials.gov/show/NCT00389948
165662165662Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal BleedingCompletedNo Results AvailableArteriovenous Malformation|Hereditary Hemorrhagic Telangiectasia|Hematochezia|MelenaDrug: Thalidomidehttps://ClinicalTrials.gov/show/NCT00389935
165663165663Lapatinib and Vinorelbine in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: lapatinib ditosylate|Drug: vinorelbine ditartrate|Genetic: comparative genomic hybridization|Genetic: cytogenetic analysis|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: polymerase chain reaction|Genetic: polymorphism analysis|Genetic: proteomic profiling|Genetic: reverse transcriptase-polymerase chain reaction|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Drug: lapatinib ditosylate|Drug: Vinorelbine ditartratehttps://ClinicalTrials.gov/show/NCT00389922
165664165664Dosing Chart for Calculating the First Dose of Doxapram in Premature InfantsCompletedNo Results AvailablePremature Infants|ApneaDrug: Doxapramhttps://ClinicalTrials.gov/show/NCT00389909
165665165665A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)CompletedNo Results AvailableHDL CholesterolDrug: MK0733 / Duration of Treatment: 18 Weeks|Drug: Comparator: placebo (unspecified) / Duration of Treatment: 18 Weekshttps://ClinicalTrials.gov/show/NCT00389896
165666165666Anaesthesia for Supratentorial Tumor ResectionCompletedNo Results AvailableSupratentorial NeoplasmsDrug: Comparison of two anesthetics protocolhttps://ClinicalTrials.gov/show/NCT00389883
165667165667Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to FluorouracilRecruitingNo Results AvailableColorectal CancerBiological: panitumumab|Drug: cyclosporine|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00389870
165668165668Trial to Collect Safety Data and Sera for Immunogenicity TestingCompletedHas ResultsInfluenzaBiological: Influenza Virus Vaccine (Fluzone®)|Biological: Influenza Virus Vaccine (Fluzone®)https://ClinicalTrials.gov/show/NCT00389857
165669165669BHS5 - Testing the Effectiveness of the Exercise Plus ProgramCompletedNo Results AvailableHip FractureBehavioral: Exercise Trainer component of the Exercise Plus Program|Behavioral: Plus component (motivation) of the Exercise Plus Program|Behavioral: Exercise Plus Program (exercise + motivation)https://ClinicalTrials.gov/show/NCT00389844
165670165670Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS SymptomsCompletedHas ResultsRestless Legs SyndromeDrug: Rotigotine Nasal Spray|Other: Placebo Nasal Sprayhttps://ClinicalTrials.gov/show/NCT00389831
165671165671Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's LymphomaCompletedHas ResultsLymphomaBiological: filgrastim|Biological: pegfilgrastim|Biological: rituximab|Biological: sargramostim|Drug: cyclophosphamide|Drug: pegylated liposomal doxorubicin hydrochloride|Drug: prednisone|Drug: vincristine sulfate|Other: immunohistochemistry staining method|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00389818
165672165672Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNo Results AvailableLung Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: bortezomib|Drug: pemetrexed disodium|Genetic: gene expression analysis|Genetic: mutation analysis|Genetic: protein expression analysis|Genetic: reverse transcriptase-polymerase chain reaction|Other: flow cytometry|Other: immunoenzyme technique|Other: immunohistochemistry staining methodhttps://ClinicalTrials.gov/show/NCT00389805
165673165673Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With PacemakersCompletedNo Results AvailableAtrial FibrillationDrug: ATI-2042|Drug: ATI-2042 200 mghttps://ClinicalTrials.gov/show/NCT00389792
165674165674DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant HypertensionCompletedNo Results AvailableHypertensionDrug: Darusentan|Drug: Guanfacine|Drug: Darusentan Placebohttps://ClinicalTrials.gov/show/NCT00389779
165675165675High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk NeuroblastomaWithdrawnNo Results AvailableNeuroblastomaDrug: iodine I 131 metaiodobenzylguanidine|Drug: topotecan hydrochloride|Procedure: chemotherapy|Procedure: peripheral blood stem cell transplantation|Procedure: radioisotope therapy|Procedure: radionuclide imaging|Procedure: radiosensitization|Procedure: total-body irradiationhttps://ClinicalTrials.gov/show/NCT00389766
165676165676Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound ClosureSuspendedNo Results AvailableHydration of ScarsDrug: Application of Aruba Aloë formula F-BC-096 or controlhttps://ClinicalTrials.gov/show/NCT00389753
165677165677A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)CompletedNo Results AvailableOsteoporosis, PostmenopausalDrug: MK0217, /Duration of Treatment : 12 Months|Drug: Comparator : raloxifene hydrochloride /Duration of Treatment : 12 Monthshttps://ClinicalTrials.gov/show/NCT00389740
165678165678Simultaneous Integrated Boost (SIB)- IMRTRecruitingNo Results AvailableCarcinoma, Squamous CellProcedure: Radiotherapyhttps://ClinicalTrials.gov/show/NCT00389727
165679165679Clinical Evaluation of Esthetic Restorations Placed in Primary Molars With Composite Resin Enriched With Insoluble Anti Bacterial Nano ParticlesNot yet recruitingNo Results AvailableDental Carious|Dental FillingDevice: dental restorationhttps://ClinicalTrials.gov/show/NCT00389714
165680165680Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to TreatmentRecruitingNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmDrug: bortezomib|Drug: dexamethasonehttps://ClinicalTrials.gov/show/NCT00389701
165681165681Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by SurgeryTerminatedNo Results AvailableLung CancerDrug: cisplatin|Drug: pemetrexed disodium|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00389688
165682165682DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant HypertensionTerminatedNo Results AvailableHypertensionDrug: Darusentan|Drug: Guanfacinehttps://ClinicalTrials.gov/show/NCT00389675
165683165683The Effect of Wearing the 'Nike Free'Shoe on Isokinetic Muscle Strength of Foot and Ankle and on Proprioception.CompletedNo Results AvailableHealthyDevice: Wearing the "Nike Free" shoehttps://ClinicalTrials.gov/show/NCT00389662
165684165684Effect of Chronic Changes in Heart Rate on Congestive Heart FailureCompletedNo Results AvailableHeart Failure, CongestiveDevice: heart rate settinghttps://ClinicalTrials.gov/show/NCT00389649
165685165685TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot UlcersActive, not recruitingNo Results AvailableDiabetic Foot UlcerDevice: TheraGauze|Drug: Regranexhttps://ClinicalTrials.gov/show/NCT00389636
165686165686Vaccine Therapy in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryActive, not recruitingNo Results AvailablePancreatic CancerBiological: allogenic GM-CSF plasmid-transfected pancreatic tumor cell vaccinehttps://ClinicalTrials.gov/show/NCT00389610
165687165687LDR Spine USA Mobi-C(R) Cervical Disc Prosthesis IDEActive, not recruitingHas ResultsDegenerative Disc DiseaseDevice: Cervical Artificial Dischttps://ClinicalTrials.gov/show/NCT00389597
165688165688Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid TumorsCompletedNo Results AvailableBrain and Central Nervous System Tumors|Cognitive/Functional Effects|Long-term Effects Secondary to Cancer Therapy in Adults|Long-term Effects Secondary to Cancer Therapy in Children|Poor Performance Status|Unspecified Adult Solid Tumor, Protocol SpecificDrug: irinotecan hydrochloride|Procedure: cognitive assessment|Procedure: management of therapy complications|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00389584
165689165689Antiseptic Use and Dressing ApplicationCompletedNo Results AvailableSkin Colonization|Catheterization|Bacterial InfectionProcedure: disinfection efficacy using Biseptine|Procedure: disinfection efficacy using Amukinhttps://ClinicalTrials.gov/show/NCT00389558
165690165690Intracoronary Stem Cells in Large Myocardial InfarctionActive, not recruitingNo Results AvailableMyocardial InfarctionProcedure: Intracoronary infusion of autologous bone-marrow derived stem cellshttps://ClinicalTrials.gov/show/NCT00389545

* Görseller ve İçerik tekif hakkına sahip olabilir